55 Corporate Drive, Bridgewater, NJ 08807, United States
Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health, and the new G enzyme. Its products include prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines, and other medical products. The...
Sanofi provides prescription and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, Respiratory and inflammatory diseases, vaccines, and rheumatic diseases.
Sanofi's major research and development areas are Oncology, Immunology & Inflammation, Rare Blood Disorders, Rare and Neurologic Diseases, Diabetes & Cardiovascular (DCV), and Vaccines.
Flublok Quadrivalent Influenza Vaccine
Flublok Quadrivalent is a vaccine for the prevention of influenza disease caused by influenza A and B given to people 18 years of age and older.
Kevzara is a fully-human monoclonal antibody for rheumatoid arthritis that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor. The med is on clinical trails to combat Covid-19 coronavirus infection.
Influenza Vaccine and COVID-19 program
Sanofi has entered into an agreement with BARDA to establish facilities in the US for the production of an adjuvanted recombinant va...
Kevzara to treat severe COVID-19
Sanofi and Regeneron Pharmaceuticals have started a clinical trial program evaluating Kevzara a rheumatoid arthritis drug to treat h...
Corporate Social Responsibility (CSR) Recognition
Sanofi U.S. distinguished for 10th consecutive year in field of Corporate Social Responsibility (...